- Release Date: 25/02/15 10:05
- Summary: Neuren reports 2014 full-year financial results
- Price Sensitive: No
- Download Document 142.13KB
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren reports 2014 full-year financial results
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.63%
!
$14.11

Ann: Neuren reports 2014 full-year financial results
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.11 |
Change
-0.090(0.63%) |
Mkt cap ! $1.750B |
Open | High | Low | Value | Volume |
$14.23 | $14.71 | $14.01 | $6.213M | 438.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7700 | $14.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.16 | 3278 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 89 | 14.810 |
1 | 10 | 14.500 |
8 | 5397 | 14.000 |
1 | 357 | 13.970 |
1 | 4800 | 13.920 |
Price($) | Vol. | No. |
---|---|---|
13.260 | 3 | 2 |
13.410 | 100 | 1 |
14.000 | 20 | 1 |
14.100 | 149 | 1 |
14.110 | 100 | 1 |
Last trade - 16.16pm 30/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online